BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30475232)

  • 1. Amisulpride for the Rescue Treatment of Postoperative Nausea or Vomiting in Patients Failing Prophylaxis: A Randomized, Placebo-controlled Phase III Trial.
    Habib AS; Kranke P; Bergese SD; Chung F; Ayad S; Siddiqui N; Motsch J; Leiman DG; Melson TI; Diemunsch P; Fox GM; Candiotti KA
    Anesthesiology; 2019 Feb; 130(2):203-212. PubMed ID: 30475232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amisulpride Prevents Postoperative Nausea and Vomiting in Patients at High Risk: A Randomized, Double-blind, Placebo-controlled Trial.
    Kranke P; Bergese SD; Minkowitz HS; Melson TI; Leiman DG; Candiotti KA; Liu N; Eberhart L; Habib AS; Wallenborn J; Kovac AL; Diemunsch P; Fox G; Gan TJ
    Anesthesiology; 2018 Jun; 128(6):1099-1106. PubMed ID: 29543631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, Double-Blind, Placebo-Controlled Study of Intravenous Amisulpride as Treatment of Established Postoperative Nausea and Vomiting in Patients Who Have Had No Prior Prophylaxis.
    Candiotti KA; Kranke P; Bergese SD; Melson TI; Motsch J; Siddiqui N; Chung F; Rodriguez Y; Minkowitz HS; Ayad SS; Diemunsch P; Fox G
    Anesth Analg; 2019 Jun; 128(6):1098-1105. PubMed ID: 31094774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous Amisulpride for the Prevention of Postoperative Nausea and Vomiting: Two Concurrent, Randomized, Double-blind, Placebo-controlled Trials.
    Gan TJ; Kranke P; Minkowitz HS; Bergese SD; Motsch J; Eberhart L; Leiman DG; Melson TI; Chassard D; Kovac AL; Candiotti KA; Fox G; Diemunsch P
    Anesthesiology; 2017 Feb; 126(2):268-275. PubMed ID: 27902493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I.V. APD421 (amisulpride) prevents postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled, multicentre trial.
    Kranke P; Eberhart L; Motsch J; Chassard D; Wallenborn J; Diemunsch P; Liu N; Keh D; Bouaziz H; Bergis M; Fox G; Gan TJ
    Br J Anaesth; 2013 Dec; 111(6):938-45. PubMed ID: 23872464
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amisulpride prevents nausea and vomiting associated with highly emetogenic chemotherapy: a randomised, double-blind, placebo-controlled, dose-ranging trial.
    Herrstedt J; Summers Y; Jordan K; von Pawel J; Jakobsen AH; Ewertz M; Chan S; Naik JD; Karthaus M; Dubey S; Davis R; Fox GM
    Support Care Cancer; 2019 Jul; 27(7):2699-2705. PubMed ID: 30488222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amisulpride: A Review in Post-Operative Nausea and Vomiting.
    Kang C; Shirley M
    Drugs; 2021 Feb; 81(3):367-375. PubMed ID: 33656662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of amisulpride on postoperative nausea and vomiting: a systematic review and meta-analysis.
    Zhang LF; Zhang CF; Tang WX; He L; Liu Y; Tian DD; Ai YQ
    Eur J Clin Pharmacol; 2020 Jul; 76(7):903-912. PubMed ID: 32274525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Amisulpride Does Not Meaningfully Prolong the QTc Interval at Doses Effective for the Management of Postoperative Nausea and Vomiting.
    Fox GM; Albayaty M; Walker JL; Xue H; Darpo B
    Anesth Analg; 2021 Jan; 132(1):150-159. PubMed ID: 31913911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An overview of intravenous amisulpride as a new therapeutic option for the prophylaxis and treatment of postoperative nausea and vomiting.
    Smyla N; Koch T; Eberhart LH; Gehling M
    Expert Opin Pharmacother; 2020 Apr; 21(5):517-522. PubMed ID: 31971450
    [No Abstract]   [Full Text] [Related]  

  • 11. Efficacy of repeat intravenous dosing of ondansetron in controlling postoperative nausea and vomiting: a randomized, double-blind, placebo-controlled multicenter trial.
    Kovac AL; O'Connor TA; Pearman MH; Kekoler LJ; Edmondson D; Baughman VL; Angel JJ; Campbell C; Jense HG; Mingus M; Shahvari MB; Creed MR
    J Clin Anesth; 1999 Sep; 11(6):453-9. PubMed ID: 10526822
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous buspirone for the prevention of postoperative nausea and vomiting.
    Kranke P; Röhm KD; Diemunsch P; Gan TJ; Apfel CC; Eberhart L; Minkowitz HS; Wallenborn J; Chassard D; Lebuffe G; Fox GM; Tramèr MR
    Eur J Clin Pharmacol; 2012 Nov; 68(11):1465-72. PubMed ID: 22546895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of granisetron for the treatment of postoperative nausea and vomiting in women undergoing breast surgery: a randomised, double-blind, placebo-controlled trial.
    Fujii Y; Tanaka H
    Clin Drug Investig; 2006; 26(4):203-8. PubMed ID: 17163252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the efficacy, safety, and patient satisfaction of ondansetron versus droperidol as antiemetics for elective outpatient surgical procedures. S3A-409 and S3A-410 Study Groups.
    Fortney JT; Gan TJ; Graczyk S; Wetchler B; Melson T; Khalil S; McKenzie R; Parrillo S; Glass PS; Moote C; Wermeling D; Parasuraman TV; Duncan B; Creed MR
    Anesth Analg; 1998 Apr; 86(4):731-8. PubMed ID: 9539593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Substance P (Neurokinin-1) antagonist prevents postoperative vomiting after abdominal hysterectomy procedures.
    Gesztesi Z; Scuderi PE; White PF; Wright W; Wender RH; D'Angelo R; Black LS; Dalby PL; MacLean D
    Anesthesiology; 2000 Oct; 93(4):931-7. PubMed ID: 11020741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the Role of Preoperative Oral Amisulpride as Part of a Multimodal Antiemetic Prophylaxis Regime on Postoperative Nausea and Vomiting in Patients Undergoing Craniotomy: A Prospective, Double-Blind, Randomized, Placebo-controlled Study.
    Gupta A; Gupta D; Gupta P; Haldar R; Verma R; Mishra P; Srivastava S
    J Neurosurg Anesthesiol; 2023 Aug; ():. PubMed ID: 37604488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravenous, oral, and the combination of intravenous and oral ramosetron for the prevention of nausea and vomiting after laparoscopic cholecystectomy: a randomized, double-blind, controlled trial.
    Ryu JH; Jeon YT; Hwang JW; Oh AY; Moon JY; Ro YJ; Kim CS; Chen C; Apfel CC; Do SH
    Clin Ther; 2011 Sep; 33(9):1162-72. PubMed ID: 21856001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a prospective, randomized, double-blind, placebo-controlled, dose-ranging trial to determine the effective dose of ramosetron for the prevention of vomiting after tonsillectomy in children.
    Fujii Y; Tanaka H
    Clin Ther; 2003 Dec; 25(12):3135-42. PubMed ID: 14749151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized, double-blind, multicenter trial comparing transdermal scopolamine plus ondansetron to ondansetron alone for the prevention of postoperative nausea and vomiting in the outpatient setting.
    Gan TJ; Sinha AC; Kovac AL; Jones RK; Cohen SA; Battikha JP; Deutsch JS; Pergolizzi JV; ; Glass PS
    Anesth Analg; 2009 May; 108(5):1498-504. PubMed ID: 19372328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative nausea and vomiting after surgery for prognathism: not only a question of patients' comfort. A placebo-controlled comparison of dolasetron and droperidol.
    Piper SN; Röhm K; Boldt J; Kranke P; Maleck W; Seifert R; Suttner S
    J Craniomaxillofac Surg; 2008 Apr; 36(3):173-179. PubMed ID: 18353666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.